Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world observational study of benvitimod cream in psoriasis
ChiCTR2000041261Phase 4Recruiting
- Sponsor
- Yuanxin Technology
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tapinarof in psoriasis, sponsored by Yuanxin Technology. Primary endpoint: Psoriasis Area and Severity Index (PASI) at 12 weeks. Started Nov 2020; status: recruiting.
02
Drugs
tapinarof
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2000041261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041261.